NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
1 hedge funds and large institutions have $0 invested in NxStage Medical Inc. in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $112M → $0 (-$112M)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAL
TIG Advisors LLC
New York
|
-$112M |
NXTM Hedge Fund Activity: Q2 2019 in Review
1 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q2 2019, worth a combined $0 — down 100% from $112M a quarter earlier.
Fund positioning in NXTM was balanced in Q2 2019: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was TIG Advisors LLC, exiting entirely with an estimated $112M sold.
- 1 institutional investor held NxStage Medical Inc. (NXTM) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $0 of NxStage Medical Inc. stock for Q2 2019, down 100% quarter-over-quarter.
- 1 fund opened new NxStage Medical Inc. positions in Q2 2019 and 1 closed out, a net change of 0 holders.
- The largest NxStage Medical Inc. seller in Q2 2019 was TIG Advisors LLC, an estimated $112M sold.
Based on aggregated 13F filings for Q2 2019.